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CC BY-NC-ND license (http://creativeAbstract Objective: In this study, the influence of puerarin, paeoniflorin, and menthol on
the structure and barrier function of tight junctions (TJs) in MadineDarby canine kidney
epithelial (MDCK) and MDCK-multi-drug resistance 1 (MDR1) cells was evaluated to determine
the mechanisms by which the drugs cross the bloodebrain barrier (BBB).
Method: Cells were treated with puerarin, paeoniflorin, and menthol followed by immunohis-
tochemical staining with occludin, claudin-1, and F-actin. The cells were then observed using
laser-scanning confocal microscopy. Average optical density (AOD) of the immunofluorescence
images of the proteins were analyzed using ImageJ software while Transepithelial electrical
resistance (TEER) was measured using an epithelial voltohmmeter.
Results: Confocal microscopy revealed that puerarin- and paeoniflorin-treated tight junction
proteins were conspicuous while menthol suppressed their expression. Correspondingly, AOD
values of cells treated with puerarin or paeoniflorin, or both showed no difference compared
to the control group (P > .05) while the menthol group value was downregulated. In 3 h, TEER
of cells not treated with menthol were similar to the control group, while treatment with
menthol significantly decreased TEER value (P < .05). In addition, application of menthol
decreased TEER in MDCK cells earlier than in MDCK-MDR1 cells.
Conclusion: Menthol but not puerarin and paeoniflorin may enhance paracellular transport and
improve drug penetration of the BBB by disrupting the structure and, thereby, weakening the
barrier function of TJs.
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112 L. Zhang et al.IntroductionBrain-targeting drugs often fail to penetrate the brain or
their levels are insufficient at their brain targets. Inade-
quate brain drug levels are usually because of the barrier
function of the brain capillary endothelial cells, which form
the bloodebrain barrier (BBB) that controls and regulates
the molecular permeation between the brain periphery and
interior.1e4 MadineDarby canine kidney epithelial (MDCK)
cells and MDCK cells transfected with the human multidrug
resistance 1 (MDR1) gene (MDCK-MDR1) are widely regarded
as an excellent cell model to simulate the BBB in vitro.5,6 In
the BBB, a single layer of the brain capillary endothelial
cells connected by tight junctions (TJs) composes a barrier
system that maintain a stable internal environment and
ensures the normal functions of the brain. TJs play a vital
role in molecular permeation of the BBB, especially for
molecules that pass through the paracellular pathway. They
distinguish the apical from the basolateral cell surface re-
gions to define cell polarity, and possess a fence and barrier
function.7e10 Under electron microscopy, TJs are visualized
as a domain of close membranes fused at the lumen-facing
apex of adjacent cells, and consist of integral membrane
proteins.11e13 MDCK and MDCK-MDR1 cells have been shown
to have analogous TJ structures consisting of brain capillary
endothelial cells and therefore express diverse TJ proteins,
including occludin, claudins, zona occuldens protein 1 (ZO-
1) and F-actin.14e16 The intramembranous fence and hy-
drophobic barrier function of TJs restrict drug delivery to
underlying tissues and, thereby, decreases drug permeation
of the BBB. In turn, since the tightness of TJs is determined
by the protein composition of the webs of the associated
proteinaceous filaments (called strands), some drugs can
alter the TJ structure and properties by acting on TJ pro-
teins to enhance their brain permeability or that of other
drugs or both. Therefore, studying the effect of compounds
on TJ proteins and mechanisms that can overcome the
paracellular barrier of the BBB is critical for the develop-
ment of brain-targeted medicines and efficacious treat-
ment of diseases.
Tongqiaosanyu is a traditional Chinese medicinal for-
mula that is prescribed as an integral part of the folkloric
clinical experience. The formula is composed of a number
of herbs, including kudzu root (Pueraria lobata), white
peony root (Paeonia albiflora), and mint (Mentha hap-
localyx Briq.). In China, Tongqiaosanyu is used to treat
stroke. Pharmacodynamic screening has identified puer-
arin, paeoniflorin, and mentholas the main active constit-
uents. Puerarin (8-[beta-D-glucopyranosyl]-7-hydroxy-3-[4-
hydroxyphenyl]-4H-1-benzopyran-4-one, C21H20O9), which
is the major isoflavone glycoside isolated from kudzu root,
has numerous clinical indications and has been widely used
for the treatment of cardiovascular disorders and ischemic
stroke in TCM.17e19 Paeoniflorin (5beta-[{Benzoyloxy}
methyl]tetrahydro-5-hydroxy-2-methyl-2,5-methano-1H-
3,4-dioxacyclobuta[cd]pentalen-1alpha[2H]-yl-beta-D-glu-
copyranoside, C23H28O11) is a monoterpene glucoside iso-
lated from white peony root. It has antithrombotic, anti-
inflammatory, anti-allergy, antihyperglycemic, glucose up-
take enhancing, and neuroprotective effects.20 Menthol (2-
isopropyl-5-methylcyclohexanol, C10H20O) is a majorconstituent of peppermint oil and possesses central nervous
system (CNS) excitatory effects and enhances BBB perme-
ation.21 Our previous investigation of Tongqiaosanyu
established analytical methods for the main active con-
stituents. In addition, we explored different administration
routes of Tongqiaosanyu, its in vivo pharmacokinetic
behavior, as well as its compatibility with other medicines.
Cytotoxicity and transport of puerarin (alone or with other
constituents in the prescription) in MDCK and MDCK-MDR1
cells have been reported, including the mechanisms by
which puerarin penetrates the BBB. However, the mecha-
nisms of action underlying the paracellular transport of
these compounds through the BBB, especially their influ-
ence on protein structure and barrier function, remain
unclear. Therefore, we sought to determine the effect of
this formula TJs, as well as the transport role of each
compound using MDCK and MDCK-MDR1 cells to simulate the
BBB. Absorption mechanism mediating the penetration of
these drugs into the brain and the penetration-enhancing
effects of some drugs were studied.
Materials and methods
Materials
Puerarin, paeoniflorin, and menthol were purchased from
the National Institute for Food and Drug Control (Beijing,
China). Polyester (PET) cell culture inserts and 12-well
plates (12-mm diameter, 0.4-mm pore size) were obtained
from Corning Life Sciences (Corning, NY, USA). Rabbit anti-
occludin antibody (ab31721) was obtained from Abcam
Shanghai (Shanghai, China). Mouse anti-claudin-1 antibody
(2H10D10) was purchased from Invitrogen (Camarillo, CA,
USA). Anti-rabbit IgG -tetramethylrhodamineisothiocyanate
(TRITC) conjugate was purchased from ZSG-BIO (Beijing,
China). Anti-mouse-fluoresceinisothiocyanate (FITC) con-
jugated antibody was purchased from Kangwei Century
Biotechnology (Beijing, China). Acti-stain 488 phalloidin
staining for F-actin was obtained from Cytoskeleton (Den-
ver, CO, USA).
Cell culture
MDCK and MDCK-MDR1 cells were generously provided by
Dr. Zeng (Zhejiang University, China). Both cell lines were
cultured with Dulbecco’s modified Eagle’s media (DMEM)
supplemented with 10% heat-inactivated fetal bovine
serum (FBS, Gibco, Fremont, CA, USA), 100 U/mL penicillin,
and 0.1 mg/mL streptomycin in a humidified atmosphere of
5% CO2 at 37
C. The medium was replaced with fresh me-
dium every other day until the cells reached approximately
90% confluence.
Grouping and drug administration
In a previous study,22 the cytotoxicity of puerarin, paeoni-
florin, and menthol in MDCK and MDCK-MDR1 cells using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetr-azolium bro-
mide (MTT) assay. Results showed puerarin, paeoniflorin,
and menthol were not cytotoxic at concentration ranges of
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tively. Furthermore, puerarin plus paeoniflorin (1:0.4 w/v,
PP), puerarin plus menthol (1:0.5 w/v, PM), and puerarin
plus paeoniflorin plus menthol (1:0.4:0.5, w/w/w, PPM)
groups exhibited no cytotoxicity at concentration ranges of
0e0.2 mg/mL (paeoniflorin), 0e0.05 mg/mL (menthol), and
0e0.04 mg/mL (menthol), respectively. Based on the re-
sults of MTT assay, this study included the following six
treatment groups: puerarin, paeoniflorin, and menthol
(0.1 mg/mL, 0.04 mg/mL, and 0.05 mg/mL, respectively),
as well as the PP group (0.1 mg/mL puerarin and 0.04 mg/
mL paeoniflorin, respectively), PM group (0.1 mg/mL
puerarin and 0.05 mg/mL menthol, respectively), and PPM
group (0.1 mg/mL puerarin, 0.04 mg/mL paeoniflorin, and
0.05 mg/mL menthol, respectively) groups.
Immunofluorescence microscopy
For immunocytochemical analysis, the cells were seeded on
15 mm coated glass coverslips. When cell fusion attained
approximately 80e90%, the regular media were replaced
with media containing the various compounds (puerarin,
paeoniflorin, or menthol at 0.1 mg/mL, 0.04 mg/mL and
0.05 mg/mL, respectively) and the cells were further
cultured for 3 h, and then fixed with cold 4% para-
formaldehyde for 30 min. After washing thrice for
5 min each with phosphate-buffered saline (PBS), the cov-
erslips were incubated for 1 h with goat serum as the
blocking buffer. Then, after rinsing with PBS thrice, some
coverslips were incubated with polyclonal anti-occludin or
monoclonal anti-claudin-1primary antibodies (1:100, each)
at 4Covernight followed by incubation with TRITC-
conjugated anti-rabbit IgG or FITC-conjugated anti-mouse
IgG. Other cells were only stained with Acti-stain 488
phalloidin stain (1:150) at 25C for 30 min. Cell nuclei were
counterstained with 40, 6-diamidino-2-phenylindole (DAPI,
Beijing Solarbio Science and Technology, Beijing, China).
The cells were visualized using an inverted fluorescence
microscope equipped with appropriate filters (Olympus,
Tokyo, Japan). Images were acquired using a laser scanning
confocal microscope and accompanying analysis software.
Fluorescence intensity of the images was measured using
ImageJ software (National Institutes of Health, Bethesda,
MD, USA).
Measurement of transepithelial electrical
resistance
To investigate changes in the TJs barrier function of the
MDCK and MDCK-MDR1 cells, transepithelial electrical
resistance (TEER) of the monolayers was detected using the
EVOM epithelial voltohmmeter (EMD Millipore, Billerica,
MA, USA). Both cell types were cultured separately
on0.4 mm pore size filters of 12 mm Transwellsand grown to
confluence. Then, 0.5 mL and 1.5 mL of drug solution and
Hank’s basic salt solution (HBSS) were added to the apical
(A) side and basolateral (B) side, respectively to simulate
A / B transport while in a parallel experiment, B / A
transport was simulated by reversing the order of the drug
solution and HBSS. TEER of untreated or puerarin-, paeo-
niflorin-, and menthol-treated cells or those treated withthe previously described drug combinations was measured
at 30, 60, 90,120,150, and 180 min. TEER was measured
immediately following drug treatment (0 min) and was set
to 100%, with all the other values calculated and expressed
relative to this value. Finally, TEER at each time point was
compared to that of the control group and statistically
analyzed.
Data analysis and statistics
Immunofluorescence images were analyzed semi-
quantitatively using ImageJ software based on the following
equations:
AODZ
IntDen
Area
ð1Þ
where IntDen is the integrated optical density (IOD) of the
image, Area is the region of fluorescence in the image, and
AOD is the average optical density.
Percentage AOD (%) of the TJ proteins was calculated
using the following equation:
Relative AOD ð%ÞZAODsample
AODcontrol
 100 ð2Þ
where AODsample and AODcontrol are the AODs of the sample
and control, respectively.
Percentage TEER was calculated using the following
equation:
Relative TEER ð%ÞZTEERt
TEERt0
 100 ð3Þ
where TEERt is the TEER value at different times and TEERt0
is the initial TEER value before the experiment was
performed.
Results are presented as means (SD) of 3 separate par-
allel experiments. Data were analyzed using a one-way
analysis of variance (ANOVA), followed by Dunnett’s test to
determine the difference between multiple groups
compared to the control group using SPSS version 17.0
software. A P < .05 was considered statistically significant.
Results
Effect of compounds on expression of TJ proteins
To determine the effects of the compounds on TJ proteins
of the MDCK and MDCK-MDR1 cells, we immunohis-
tochemically analyzed occludin, claudin-1, and F-actin
using laser scanning confocal microscopy (Fig. 1). All three
TJ proteins showed positive staining in both cell types and
occludin stained red, claudin-1and F-actin stained green,
and the nuclei stained blue. Both cell types had similar TJ
barrier function systems. After treatment with puerarin and
paeoniflorin, the visual morphology of occludin, claudin-1,
and F-actin in both kinds of cells was not difference from
that of the untreated cells. However, incubation with
menthol, decreased the TJ proteins in both MDCK and
MDCK-MDR1-cells and the morphology was hardly observed
(Fig. 1A, B, respectively).
Fig. 1 Effect of puerarin, paeoniflorin, and menthol on tight junction (TJ) proteins in (A) MadineDarby canine kidney epithelial
(MDCK) and (B) MDCK-multi-drug resistance 1 (MDR1) cells (600). (A) Immunocytochemistry for occluding, claudin-1, and F-actin in
MDCK cells with puerarin or paeoniflorin showed similar fluorescent morphology with the control group. All three proteins were
deceased in MDCK cells by menthol. (B) Fluorescence intensity in MDCK-MDR1 cells with different compounds was similar to that in
MDCK cells. Scale bar corresponds to 1.0 mm.
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different compounds
Fluorescence intensity of the immunofluorescent images
was semi-quantitatively analyzed. AOD values of each
protein were calculated using ImageJ software and statis-
tical analysis was conducted (Fig. 2). The control, puerarin,
and paeoniflorin groups showed similar approximate rela-
tive AOD values in the MDCK and MDCK-MDR1 cells, while
the menthol group was significantly different compared to
the control group (P < .05).
Changes in TEER of cells treated with various
compounds
To determine the effects of the compounds on the function
of the TJ barrier, we measured the TEER values of MDCK
and MDCK-MDR1 cells after exposure to the variousFig. 2 Change in relative average optical density (AOD) of
occludin, claudin-1, and F-actin in (A) MadineDarby canine
kidney (MDCK) epithelial and (B) MDCK-multi-drug resistance 1
(MDR1) cells after treatment with different compounds. (A)
Relative AOD values of tight junction (TJ) proteins in MDCK
cells treated with puerarin or paeoniflorin showed no signifi-
cant difference compared to the control group while AOD
values of the menthol group were significantly reduced. (B)
Relative AOD values in MDCK-MDR1 cells treated with different
compounds were the same as in MDCK cells. Only menthol
reduced AOD of all three proteins. Data presented as mean (SD)
(n Z 3). )P < .05 compared to control group.compounds for up to 3 h. TEER values of each group treated
with the compounds for different times were statistically
compared with those of the control group (Fig. 3). MDCK
cells (Fig. 3A) treated with puerarin, paeoniflorin, and PP
exhibited similar changes in TEER compared to the control
group in the A / B and B / A transport processes. At
90 min, TEER of the menthol, PM, and PPM groups
decreased significantly compared with that of the control
group (P < .05). In MDCK-MDR1 cells (Fig. 3B), groups not
treated with menthol exhibited a steady TEER change
similar to the control group and menthol-treated groups
showed a significant decrease at 120 min(P < .05)in both
the A / B and B / A transport processes compared to
control.Discussion
Use of both in vivo and in vitro methods has led to the
elucidation of certain aspects of the drug transport process
across the BBB. In vivo studies of the BBB provide valuable
observational information and direct analysis of drug
permeation processes such as drug distribution in each
brain region. However, there are some limitations and
shortcomings to this method including the laborious nature
of the experiments, individual differences, and compli-
cated analytical methods. Accordingly, development of
in vitro models is highly desired to facilitate the clarifica-
tion of the BBB permeability mechanisms. Such desired
models mainly include those that would predict the asso-
ciated BBB processes using computer simulation technol-
ogy, parallel artificial membrane permeability assay
(PAMPA), and in vitro cell culture techniques.6 Cell culture
is currently the favored tool for simultaneously obtaining
complex and comprehensive information of passive and
active transport processes. Generally, there are two types
of cell culture models that are used to simulate the BBB.
One consists of the “real BBB model,” which is based on
primary cultures of brain capillary endothelial cells or sin-
gle cell lines that may be complemented or co-cultured
with astrocytes/pericytes.23,24 The other type is the “sur-
rogate BBB model,” which uses similar epithelial cells such
as MDCK, MDCK-MDR1,and human colon carcinoma cell lines
(Caco-2).5,25,26 Among these, MDCK and MDCK-MDR1 have
been recognized as the ideal models for in vitro simulation
of BBB drug penetration.6,27e29 They have several advan-
tages including (1) stable source with no batch-to-batch
variability, (2) convenient for routine experimental appli-
cation and thus reduce labor intensity, (3) adequately and
closely mimic relevant in vivo properties of the BBB, (4)
ensure adequate monolayer integrity and display a proper
TEER value under conventional experimental conditions,
and (5) show superior P-glycoprotein (P-gp) expression and
activity, particularly in MDCK-MDR1 cells transfected with
the human MDR1 gene, which is a very important efflux
transporter in the BBB.30e34 Therefore, we chose MDCK and
MDR1-MDCK cells to establish our in vitro BBB model.
Drugs cross the blood brain barrier by two main
methods: transcellular and paracellular transport. In addi-
tion, numerous elements impede penetration of drugs and
substances from the extra-brain region to the brain area,
including the BBB morphologic characteristics (such as
Fig. 3 Change in transepithelial electrical resistance (TEER) in (a, b) MadineDarby canine kidney (MDCK) epithelial and (c, d)
MDCK multi-drug resistance 1 (MDCK-MDR1) cells after treatment with different compounds. (a, b) TEER of MDCK cells gradually
decreased following treatment with compounds alone or in combination with menthol. (c, d) TEER in menthol-treated MDCK-MDR1
cells similarly declined. Data presented as mean (SD) (n Z 3). PP: puerarin and paeoniflorin; PM: puerarin and menthol; PPM:
puerarin, paeoniflorin and menthol groups.
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cellular membrane, and P-glycoprotein (P-gp). For hydro-
philous compounds, paracellular transport is a crucial
pathway for penetrating the brain and exerting a thera-
peutic effect. The physiologic function of the TJ is insep-
arable from paracellular transport and its barrier and fence
functions are regulated by various factors.35e37 Using on
the simulated BBB MDCK and MDCK-MDR1 cell model, we
focused on studying the mechanism of the main active
constituents in the Tongqiaosanyu prescription to deter-
mine their effects on the structure and barrier function of
TJs.
The TJ structure is composed of various types of proteins
and occludin is regarded as the primary identifying mole-
cule of the TJ strands. It is a tetraspan membrane protein
of approximately 60-kD, with a short intracellular curve,
two extracellular annuli, and N- and C-terminals in the
cytoplasmic domain.38 Assembly of TJs and concomitant
increase in TEER have been demonstrated to be associated
with tyrosine phosphorylation of occludin, which is a phe-
nomenon commonly observed after recovery from adeno-
sine triphosphate (ATP) depletion or during calciumrepletion.39,40 Claudins have different sequences from
occluding and are 18- to 27-kDtetraspan proteins with two
extracellular annuli, a short N-terminus, and a C-terminal
in the cytoplasmic domain.41 Claudin-1 is also considered
an important strand or even the back bone of TJs.42 Recent
studies have shown that claudin-1 is the decisive compo-
nent of TJs and possesses cell adhesion activity.43 It can
directly affect the regulation of paracellular transport and
the selectivity of solute size. F-actin, which is one of the
peripheral membrane proteins of TJs, is related to organ-
elle movement, protoplasmic streaming, and intercellular
junctionregulation.7,44e47 Importantly, the F-actin belt can
control TJ function and limit the material intake.48
Although we did not investigate all TJ protein types in
MDCK and MDCK-MDR1 cells, the proteins we chose were
excellent representations. We individually analyzed the
immunofluorescence staining of occludin, claudin-1, and F-
actin in MDCK and MDCK-MDR1 cells after treatment with
puerarin, paeoniflorin, or menthol. The puerarin and
paeoniflorin group did not affect the staining properties of
TJ proteins. Only menthol inhibited the expression and
reduced the fluorescence intensity (AOD value) of all three
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cated that it directly disrupted the structure and integrity
of TJs to open the BBB barrier. These results combined with
previous reports led us to infer that disruption of the
configuration and integrity of TJ by menthol might be
caused by phosphorylation of TJ components, activation of
protein kinases, or calcium depletion.49e52
TEER measurement has been widely applied in evalu-
ating the integrity of the monolayer and studying the
permeability of transport processes. Changes in TEER
values have been directly linked to the function of the
paracellular occluding barrier53,54 TEER is caused by cell-
substrate contact, and if the distance of the cell-
substrate is short, a high TEER value is observed. Based
on this physiologic characteristic, paracellular resistance
and the average cell-substrate distance can be estimated
by the TEER. Paracellular resistance consists of the serial
resistance of the TJs as well as lateral intercellular resis-
tence.55 Therefore, to establish the relationship between
the change in TEER and the state of TJ barrier function, we
used EVOM instrumentation to determine the TEER of two
kinds of cells at different time points after treatment with
the compounds. The results were consistent with those of
immunocytochemistry, and revealed that TEER value
gradually declined following treatment of cells with
menthol, and values of the other groups were relatively
stable during the test period. Therefore, this experiment
showed that menthol is capable of weakening the BBB and
enhancing paracellular transport. The mechanism of the
decrease in TEER also involves Ca2þ influx and the Ca2þ
chelator EGTA blocked cofilin dephosphorylation. Further-
more, the alteration may have been caused by activity
variation of intrinsic membrane proteins.56 For example,
removal and addition of Ca2þ to the filter where MDCK cell
layers form a monolayer may reversibly lead to their TJs
opening and resealing, and the cell-substrate separation
may correspondingly increase or decrease.57 In addition,
we were surprised to find that reduction in TEER of the
MDCK cells occurred earlier than it did in MDCK-MDR1 cells,
which suggests that the TJ barrier in the MDCK-MDR1 was
stronger than it was in MDCK, and menthol might have a
rapid onset of action in MDCK cells.
Our previous research in rats and mice on the pharma-
cokinetics of puerarin in Tongqiaosanyu prescription used
different methods of administration, including caudal vein
injection as well as nasal and oral administration. The study
employed reversed-phase high-performance liquid
chromatography(RP-HPLC) to determine the concentration
of the puerarin in blood and brain tissue samples, which
were collected at different time points. Pharmacokinetics
in rats showed that AUC0eN following nasal administration
was 376.56  93.93 mg/min/L and absolute bioavailability
of puerarin was 47.78% by nasal administration, which was
significantly higher than oral administration. These results
were the basis for our choosing nasal administration of
Tongqiaosanyu prescription. Plasma and brain pharmaco-
kinetics in mice indicated that the brain targeting coeffi-
cient (Re) was 132.25% following intranasal administration
and the brain drug targeting index (DTI) was 2.70, both of
which were significantly higher than Re and DTI obtained
following injection administration. These results showed
that intranasal administration enhanced the medicine’spenetration and absorption into the brain.58 Furthermore,
we used the abdominal skin of the American bullfrog Rana
catesbeiana as an in vitro model to study the effect of
different concentrations of puerarin and the effect of
different proportions of menthol on the apparent perme-
ability coefficient (Papp) using the Franz diffusion cell sys-
tem and HPLC. The results showed there was no significant
difference in the effects of different concentrations of
puerarin on Papp, indicating that the permeation of puerarin
is via passive diffusion. Furthermore, when the mass con-
centration of menthol was 5 mg/L, there was a significant
difference compared with the puerarin group, which
proved that menthol enhanced the permeation of puerarin
at a certain concentrationrange.59
The main limitation of this study is that we only explored
a single drug dose. Future studies will further investigate
the dose-effect relationship. Therefore, the mechanism
underlying the effect of drugs on the TJ and transport
through the BBB needs further elucidation.Conclusion
In conclusion, this preliminary investigation demonstrated
the mechanism of puerarin, paeoniflorin, and menthol on
TJ proteins and TEER. Compared with puerarin and paeo-
niflorin, menthol in Tongqiaosanyu prescription affected
the TJ structure and function in MDCK and MDCK-MDR1
cells, which were used as in vitro BBB models. Menthol
inhibited occludin, claudin-1, and F-actin, which suggests
that it may be a potential drug for enhancing the transport
of other drugs though the BBB and, thereby, improving their
permeation in the brain. Moreover, menthol downregulated
the TEER, which verified the relationship between TJ and
TEER value, and contributed to opening the barrier to in-
crease paracellular transport. This study was carried out to
advance our understanding of the effect of puerarin,
paeoniflorin, and menthol on the BBB and provide insight
into how Tongqiaosanyu affects TJ structure and function.
The study also helps explain the interaction of drugs in a
multicomponent herbal prescription.References
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